Filing Details
- Accession Number:
- 0001593968-20-002125
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-03 20:29:14
- Reporting Period:
- 2020-11-02
- Accepted Time:
- 2020-11-03 20:29:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1673772 | Rapt Therapeutics Inc. | RAPT | Pharmaceutical Preparations (2834) | 473313701 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1783296 | C Karen Lam | C/O Rapt Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA 94080 | Vp, Finance And Controller | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-11-02 | 2,022 | $28.14 | 12,735 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.09 to $29.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- Includes 2,022 shares acquired by the reporting person under the Issuer's 2019 Employee Stock Purchase Plan on October 30, 2020.
Billionaire Hedge Funds
